Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunogenic
100%
Chronic Myeloid Leukemia
100%
Antileukemic Activity
100%
Necroptosis
100%
Indolequinone
100%
PARP Inhibitors (PARPi)
100%
Leukemia Patients
50%
Flow Cytometry
40%
Cell Death
20%
DNA Damage
20%
C57BL
20%
Transcriptome Analysis
20%
Stem Cells
20%
Energy Metabolism
20%
Resistant Cells
20%
Tyrosine Kinase Inhibitor
20%
Fluorescent Microscopy
20%
Inhibitor Resistant
20%
Damage-associated Molecular Patterns
20%
Leukemia Stem Cells
20%
Extracellular ATP (eATP)
20%
Tumor
10%
Western Blotting
10%
Synergistic Effect
10%
Immune System
10%
Therapeutic Potential
10%
Mitochondrial Dysfunction
10%
New Therapeutics
10%
Metabolic
10%
Cell-to-cell
10%
DNA Repair
10%
Drug Target
10%
Syngeneic
10%
Deregulation
10%
Metabolic Alterations
10%
Gene Signature
10%
Mitochondrial Membrane Potential
10%
Nicotinamide Adenine Dinucleotide (NAD+)
10%
Therapeutic Strategies
10%
Bioinformatics Analysis
10%
Double-strand Break Repair
10%
Leukemia Therapy
10%
Oxidative Phosphorylation (OXPHOS)
10%
Calcium Homeostasis
10%
Mitochondrial Metabolism
10%
ELISA Assay
10%
Repair Pathway
10%
Imatinib
10%
Intolerance
10%
DNA Repair Pathways
10%
Luciferase
10%
High Mobility Group Box 1 (HMGB1)
10%
Non-apoptotic Cell Death
10%
Colony Formation Assay
10%
Mitochondrial Fitness
10%
Real-time qPCR
10%
Healthy Cells
10%
ATP Production
10%
Calreticulin
10%
Catastrophe
10%
Tumor mutational Burden
10%
Molecular Docking
10%
Production Rate
10%
Homeostasis Disruption
10%
Phagocytosis Assay
10%
Myeloid Leukemia Cells
10%
Zebrafish Xenograft
10%
3-aminobenzamide
10%
Leukemia Data
10%
Immunogenic Potential
10%
Cell Persistence
10%
ROS Accumulation
10%
Trypan Blue Assay
10%
Flow Morphology
10%
ATP Assay
10%
Asciminib
10%
Calcium Accumulation
10%
DNA Repair Deficiency
10%
ATP Content
10%
In Vivo Vaccination
10%
Seahorse Analyzer
10%
Metabolic Pathways
10%
Immunological Therapy
10%
Major Challenges
10%
EGFR-TKI Resistance
10%
Chemical Reaction Prediction
10%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
PARP1
100%
Necroptosis
100%
Stem Cell
36%
Flow Cytometry
36%
DNA Repair
27%
Tyrosine Kinase Inhibitor
27%
Gene Expression Profiling
18%
DNA Damage
18%
Energy Metabolism
18%
Adenosine Triphosphate
18%
Cell Death
18%
C57BL 6 Mouse
18%
Deficiency
18%
Gene Signature
9%
Western Blot
9%
Syngenic
9%
Trypan Blue
9%
Docking (Molecular)
9%
Mitochondrial Respiration
9%
Real-Time Polymerase Chain Reaction
9%
Calreticulin
9%
Oxidative Phosphorylation
9%
Phagocytosis
9%
Calcium Homeostasis
9%
Luciferase
9%
Mitochondrial Membrane Potential
9%
Zebra Fish
9%
High-Mobility Group
9%
Seahorse
9%
Poly ADP Ribose Polymerase
9%
Colony Formation
9%
Mitochondrial Disorder
9%
Imatinib
9%
Programmed Cell Death
9%
Bioinformatics Analysis
9%
Immunology and Microbiology
Myeloid
100%
Necroptosis
100%
Stem Cell
36%
DNA Repair
27%
Tyrosine
27%
Kinase
27%
Phosphotransferase
27%
Cell Death
18%
DNA Damage
18%
Energy Metabolism
18%
C57BL 6 Mouse
18%
Gene Expression Assay
18%
Xenograft
9%
Western Blot
9%
Real-Time Polymerase Chain Reaction
9%
Leukemia Cell
9%
ELISA
9%
Mitochondrial Respiration
9%
Syngenic
9%
Phagocytosis
9%
Immunotherapy
9%
Calreticulin
9%
Oxidative Phosphorylation
9%
Mitochondrial Membrane Potential
9%
Zebra Fish
9%
Colony Formation
9%
Molecular Docking
9%
Immune System
9%
Programmed Cell Death
9%
Bioinformatics
9%
Seahorse
9%
Calcium Homeostasis
9%
Tumor Mutational Burden
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Indole Derivative
100%
Flow Cytometry
40%
Protein Tyrosine Kinase Inhibitor
30%
Adenosine Triphosphate
30%
Leukemia
20%
C57BL 6 Mouse
20%
Enzyme-Linked Immunosorbent Assay
10%
Zebra Fish
10%
Western Blot
10%
Immunotherapy
10%
Neoplasm
10%
Calreticulin
10%
Myeloid Leukemia
10%
Luciferase
10%
Imatinib
10%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
10%
3 Aminobenzamide
10%
Trypan Blue
10%
Asciminib
10%
Seahorse
10%
Vaccination
10%